What sector does BridgeBio Pharma, Inc. (2CL) operate in?
BridgeBio Pharma, Inc. belongs to the Healthcare sector and operates in the Biotechnology industry.
What is BridgeBio Pharma, Inc. (2CL) current stock price?
As of the latest data, BridgeBio Pharma, Inc. stock price is €30.74, with a previous close of €30.15. BridgeBio Pharma, Inc. gained €0.59 in the last trading session, representing a 1.96% increase.
What is BridgeBio Pharma, Inc. (2CL) current market capitalization?
BridgeBio Pharma, Inc. market cap is approximately 5.84 billion.
What is BridgeBio Pharma, Inc. (2CL) Earnings Per Share (EPS)?
The trailing EPS is -€3.15.
Does BridgeBio Pharma, Inc. (2CL) dividends?
No. BridgeBio Pharma, Inc. does not pay a dividend.
When is BridgeBio Pharma, Inc. (2CL) next earnings report?
BridgeBio Pharma, Inc. is expected to release its next earnings report on March 31, 2025.